Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth
Year: 2019
Type: article
Study design: Observational Study
Source: Journal of Adolescent Health
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Amgen, AstraZeneca, GlaxoSmithKline, BASF, North Carolina GlaxoSmithKline Foundation, Duke University, University of North Carolina, GlaxoSmithKline foundation, Novo Nordisk, National Institutes of Health, Gillings School of Public Health, BASF Corporation, University of North Carolina Wilmington, University of North Carolina at Chapel Hill, UCB US, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Mental Health, National Cancer Institute, Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, School of Medicine, University of North Carolina at Chapel Hill, North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, H2020 European Research Council
Awards: G1005728247, G1284380646, Methods for Estimating Sex Differences in Safety and Effectiveness of Drugs, Patterns of use, comparative effectiveness, and safety of rotavirus vaccines, G3855968436, G4163160421, Pediatric anxiety: Pharmacotherapy and psychotherapy utilization and serious adverse outcomes, North Carolina Translational and Clinical Science Institute (NC TraCS), PROMIS Validation in Prospective Population-based Prostate Cancer Research Study, G8414905526, Research Training Program in Psychiatric Epidemiology, Propensity scores and preventive drug use in the elderly
OpenAlex ID: W2956944868